Clinical Trial Update: A Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD7594 Administered Once Daily by Inhalation in Asthmatic Subjects [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating multiple dose levels of AZD7594 inhaled once daily in asthmatic subjects has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• AZD7594

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2020-11-27